Welcome to touchPODCAST where you can listen and learn from our expert faculty, hand-picked from the Touch Medical Media family of independent medical websites. Educating physicians on a fully global scale since 2005! We make positive changes to clinical practice, with the ultimate objective of improving patient and community health. Working alongside leading medical experts, societies and industry, our mission is to provide practical, expert opinions to support best practices for busy Healthcare Professionals globally, by translating published data into easily digestible and timely updates Home of: - touchONCOLOGY - touchENDOCRINOLOGY - touchOPHTHALMOLOGY - touchNEUROLOGY - touchCARDIOLOGY - touchINFECTIOUSDISEASES - touchIMMUNOLOGY - touchRESPIRATORY - touchHAEMATOLOGY - touchDERMATOLOGY This information is intended for use by licensed Healthcare Professionals (HCPs). It should not be considered medical advice, diagnosis, or treatment recommendations.
Episodes
Thursday Apr 14, 2022
Thursday Apr 14, 2022
touchMDT for touchENDOCRINOLOGY
Listen to key experts from a multidisciplinary team review the rationale for using GLP-1 as a therapeutic target in T2D and provide an overview of GLP-1 RA based therapies
The multidisciplinary team
- Primary Care Physician: Dr Kevin Fernando, Berwick, UK
- Endocrinologist: Prof. Dr med. Michael Nauck, Bochum, Germany
This touchPODCAST is for HCPs only.
This activity is funded by an unrestricted independent medical education grant from Novo Nordisk A/S. This activity is jointly provided by USF Health and touchIME.
For further information visit our website: https://touchendocrinologyime.org/mdt-integrating-glp1ras-t2d-management-from-pcp-to-patient/
Wednesday Apr 13, 2022
Wednesday Apr 13, 2022
touchEXPERT OPINIONS for touchIMMUNOLOGY
Listen to leading experts discuss important considerations in the optimal management of patients with moderate-to-severe ulcerative colitis.
The experts
- Prof. Ailsa Hart – St Mark’s Hospital and Academic Institute, London, UK
- Dr Gil Y Melmed – Inflammatory Bowel Disease Center, Cedars-Sinai Medical Center, Los Angeles, CA, USA
- Prof. Brian G Feagan – University of Western Ontario, London, ON, Canada
This touchPODCAST is for HCPs only.
This activity is funded by an unrestricted independent educational grant from Bristol Myers Squibb. This activity is jointly provided by USF Health and touchIME.
For further information visit our website: https://touchimmunologyime.org/improving-outcomes-uc
Tuesday Apr 12, 2022
Tuesday Apr 12, 2022
touchCONGRESS for touchRESPIRATORY
Listen to Dr Evan Dellon (USA) cover key data presented at AAAAI 2022 Annual Meeting on eosinophilic esophagitis (EoE) including risk factors and pathogenesis, burden of disease and emerging treatment options, as well as expert insights and interpretation from Dr Stuart Carr (Abu Dhabi, UAE) and Dr Alexandra Papadopoulou (Greece).
Overview
- Data review with Dr Evan Dellon (00:55)
- Expert interview with Dr Evan Dellon, Dr Stuart Carr and Dr Alexandra Papadopoulou (37:05)
Interview questions
- How do the latest data improve our understanding of the pathogenesis of EoE and what are the implications for practice? (37:40)
- How do the latest data on overlapping atopic conditions in patients with EoE correspond to the patients you manage? (42:23)
- What are the clinical implications of the data presented from the three-part, phase III trial evaluating dupilumab in patients with EoE? (48:12)
- Are the presented data on the use of single or multiple biologics in patients with overlapping atopic conditions encouraging? (53:18)
- What is your key takeaway from AAAAI 2022? (58:27)
This touchPODCAST is for HCPs only.
This activity is funded by an unrestricted independent medical educational grant from Regeneron Pharmaceuticals, Inc. and Sanofi Genzyme. This activity is provided by touchIME.
For further information visit our website: https://touchrespiratoryime.org/eoe-aaaai-2022/
Tuesday Apr 12, 2022
Tuesday Apr 12, 2022
touchCONGRESS for touchRESPIRATORY
Listen to Dr Evan Dellon (USA) cover key data presented at AAAAI 2022 Annual Meeting on eosinophilic esophagitis (EoE) including risk factors and pathogenesis, burden of disease and emerging treatment options, as well as expert insights and interpretation from Dr Stuart Carr (Abu Dhabi, UAE) and Dr Alexandra Papadopoulou (Greece).
Overview
- Data review with Dr Evan Dellon (00:55)
- Expert interview with Dr Evan Dellon, Dr Stuart Carr and Dr Alexandra Papadopoulou (37:05)
Interview questions
- How do the latest data improve our understanding of the pathogenesis of EoE and what are the implications for practice? (37:40)
- How do the latest data on overlapping atopic conditions in patients with EoE correspond to the patients you manage? (42:23)
- What are the clinical implications of the data presented from the three-part, phase III trial evaluating dupilumab in patients with EoE? (48:12)
- Are the presented data on the use of single or multiple biologics in patients with overlapping atopic conditions encouraging? (53:18)
- What is your key takeaway from AAAAI 2022? (58:27)
This touchPODCAST is for HCPs only.
This activity is funded by an unrestricted independent medical educational grant from Regeneron Pharmaceuticals, Inc. and Sanofi Genzyme. This activity is provided by touchIME.
For further information visit our website: https://touchimmunologyime.org/eoe-aaaai-2022/
Monday Apr 11, 2022
Monday Apr 11, 2022
touchPANEL DISCUSSION for touchIMMUNOLOGY
Listen to a panel of experts discuss how emerging endotypes in chronic spontaneous urticaria are driving the development of much-needed new treatment and management approaches.
The experts:
- Prof. Dr med. Marcus Maurer – Charité University Medicine, Berlin, Germany
- Dr Melinda Gooderham – SKiN Centre for Dermatology, Ontario, Canada
- Prof. David Khan – Southwestern Medical Center, University of Texas, USA
This touchPODCAST is for HCPs only.
This activity is funded by an unrestricted independent educational grant from Regeneron Pharmaceuticals, Inc. and Sanofi Genzyme. This activity is jointly provided by USF Health and touchIME.
For further information visit our website: https://touchimmunologyime.org/csu-pathogenesis-to-treatment/
Wednesday Apr 06, 2022
Wednesday Apr 06, 2022
touchTALKS for touchRESPIRATORY
Listen to Dr Parsons of the University of Colorado, Aurora, CO, USA, describe the clinical presentation and diagnosis of later-onset phenotypes of SMA, before reviewing clinical trial data for approved treatments and assessing their impact on the natural history of the disease.
This touchPODCAST is for HCPs only.
This activity is funded by an unrestricted independent medical education grant from Genentech, a member of the Roche group, and Novartis Gene Therapies, Inc. This activity is jointly provided by USF Health and touchIME.
For further information visit our website: https://touchrespiratory.com/cme/later-onset-SMA-diagnosis-treatment
Tuesday Apr 05, 2022
Tuesday Apr 05, 2022
touchTALKS for touchNEUROLOGY
Listen to Dr Parsons of the University of Colorado, Aurora, CO, USA, describe the clinical presentation and diagnosis of later-onset phenotypes of SMA, before reviewing clinical trial data for approved treatments and assessing their impact on the natural history of the disease.
This touchPODCAST is for HCPs only
This activity is funded by an unrestricted independent medical education grant from Genentech, a member of the Roche group, and Novartis Gene Therapies, Inc. This activity is jointly provided by USF Health and touchIME.
For further information visit our website: https://touchneurology.com/cme/later-onset-SMA-diagnosis-treatment
Monday Apr 04, 2022
Monday Apr 04, 2022
touchMDT for touchINFECTIOUSDISEASES
Listen to an HIV specialist, a specialist nurse and an advocate for PLHIV discuss the important role of the multidisciplinary team in optimizing adherence to ART and health of PLHIV
The experts
- HIV Specialist: Dr Laura Waters, London, UK
- Nurse Specialist; Ms Catarina Esteves, Cascais, Portugal
- Advocate for PLHIV: Ms Susan Cole, London, UK
This touchPODCAST is for HCPs only.
This activity is funded by an unrestricted independent medical education grant from ViiV Healthcare UK Ltd. This activity is provided by touchIME.
For further information visit our website: https://touchinfectiousdiseases.com/education/mdt-hiv-art-adherence/
Monday Apr 04, 2022
Monday Apr 04, 2022
touchMDT for touchINFECTIOUSDISEASES
Listen to an HIV specialist, a specialist nurse and an advocate for PLHIV discuss factors impacting quality of life and adherence to ART in PLHIV.
The multidisciplinary team
- HIV Specialist: Dr Laura Waters, London, UK
- Nurse Specialist; Ms Catarina Esteves, Cascais, Portugal
- Advocate for PLHIV: Ms Susan Cole, London, UK
This touchPODCAST is for HCPs only.
This activity is funded by an unrestricted independent medical education grant from ViiV Healthcare UK Ltd. This activity is provided by touchIME.
For further information visit our website: https://touchinfectiousdiseases.com/education/mdt-hiv-art-adherence/
Monday Apr 04, 2022
Monday Apr 04, 2022
touchMDT for touchINFECTIOUSDISEASES
Listen to an HIV specialist, a specialist nurse and a clinical pharmacist discuss how they assess readiness to start ART and barriers to adherence.
The multidisciplinary team
- HIV Specialist: Dr Laura Waters, London, UK
- Nurse Specialist; Ms Catarina Esteves, Cascais, Portugal
- Clinical Pharmacist: Ms Fiona Marra, Glasgow, UK
This touchPODCAST is for HCPs only.
This activity is funded by an unrestricted independent medical education grant from ViiV Healthcare UK Ltd. This activity is provided by touchIME.
For further information visit our website: https://touchinfectiousdiseases.com/education/mdt-hiv-art-adherence/